CASRAI Dictionary

Author: MCP Service

  • UKRI Tickell Review: Reform Progress in 2026

    The UKRI Tickell review — the Independent Review of Research Bureaucracy led by Professor Adam Tickell — set out how UK research funding should cut needless administrative drag. By mid-2026, UKRI’s Corporate Plan Update 2025 to 2027 shows real but partial delivery: a new integrated back-office platform and further Funding Service development are underway, while full economic costing harmonisation, peer-review speed-ups, and some equality, diversity and inclusion (EDI) commitments remain in progress or contested.

    The Independent Review of Research Bureaucracy is the 2021–2022 UK government review, chaired by Professor Adam Tickell, Vice-Chancellor of the University of Birmingham, that examined how funders, universities and government create unnecessary administrative burden across the research system.

    What did the Tickell review actually recommend?

    The review launched in March 2021 and reported with a 63-page final report in July 2022, examining application processes, grant management, assurance and reporting, peer review, data and digital infrastructure, and institutional culture. The UK government published its formal 53-page response on 9 February 2024, describing it as “a roadmap on how the sector will work together to reshape the research system” (GOV.UK, Independent review of research bureaucracy: government response).

    That response gave UKRI a new mandate to have “due regard for reducing bureaucracy in all new initiatives and programmes it funds.” It also committed government to reversing rising costs in the Research Excellence Framework, with the next REF cycle expected to be “significantly and measurably less bureaucratic” than its predecessor.

    • Recommendations spanning simplified applications, proportionate assurance, and harmonised costing across funders
    • A specific commitment (recommendation 12) that funders “should ensure that application processes support their commitments to equality, diversity and inclusion”
    • Creation of the Bureaucracy Review Reform and Implementation Network (BRRIN), coordinating UKRI, DSIT and sector bodies including ARMA

    What has UKRI delivered by 2026?

    UKRI’s Corporate Plan Update 2025 to 2027, published 25 November 2025, is the clearest first-party evidence of where delivery actually stands. It commits UKRI to “deliver transition to a new integrated back-office platform for human resources, accounting, reporting and procurement and optimise functionality of our Funding Service” during 2026, explicitly framing this as moving forward from “delivering the UKRI recommendations from the Tickell and Grant reviews.”

    On the applicant-facing side, UKRI’s Reducing Research Bureaucracy page (last updated 2 June 2025) confirms the Funding Service is:

    • Standardising and simplifying application processes across UKRI’s seven research councils, Innovate UK and Research England
    • Introducing consistent question sets and assessment criteria, removing requirements for unnecessary attachments
    • Streamlining full economic costing (FEC) rates into a single harmonised costing mechanism

    The Corporate Plan Update also sets a concrete operational target: UKRI states it will “demonstrate, through experiments on UKRI funding opportunities, that two-month reductions in grant processing times for research councils can be achieved using novel peer review processes that also improve assessment quality and reduce administrative resources.” Separately, it commits to “testing more proportionate approaches” and “minimising bureaucracy for the sector” as an explicit organisational objective for 2025–26.

    Where is delivery stalled or contested?

    Not every 2024 commitment has moved as originally framed. Coverage of the government response at the time noted a “potential phasing out of the use of Researchfish from 2025” — the grant outcomes collection system long criticised by researchers as burdensome. UKRI’s own Corporate Plan Update 2025 to 2027 instead commits to retendering the Researchfish system rather than replacing or discontinuing it, alongside evolving “our performance reporting framework to explore potential for greater automation.” That is a materially different outcome from the phase-out some in the sector expected.

    EDI commitments also remain contested. The government’s 2024 response took what commentators characterised as a legalistic line, stating that it does not require funders to go beyond their legal duties under the Equality Act, including “the excessive use of Equality Impact Assessments.” This sits uneasily against the review’s own recommendation 12, that application processes should actively support EDI commitments — a tension the Corporate Plan Update does not resolve.

    Parliamentary scrutiny in early 2026 also surfaced sector concern that transformation could create short-term disruption: early-career researchers in physics and astronomy raised concerns to UKRI leadership in March 2026 about funding continuity and delayed grant decisions during the transition period, even as UKRI’s CEO told the House of Commons Science, Innovation and Technology Committee that reforms would bring “greater coherence, greater clarity, greater transparency about how the money gets to output.”

    How does progress compare across the wider sector?

    The Tickell review was never a UKRI-only exercise — it targeted the whole research ecosystem, and delivery is visibly uneven across bodies with different remits and pace of change.

    Body Tickell-linked initiative 2026 status
    UKRI Integrated back-office platform + Funding Service harmonisation In active transition through 2026, per Corporate Plan Update 2025–2027
    UKRI Researchfish outcomes system Retendered, not phased out, reversing earlier 2024 signal
    NIHR Excess treatment costs (ETC) simplification Ongoing, extending bureaucracy reduction beyond NIHR’s own systems (NIHR, 27 April 2026)
    Health Research Authority “Removing barriers to research” programme Responding directly to Tickell recommendations on NHS research approvals
    ARMA / BRRIN Bureaucracy Review Reform and Implementation Network Cross-funder network active; ARMA members contribute across all workstreams
    DSIT / Research England REF cost reduction commitment Government committed to a “significantly and measurably less bureaucratic” next REF cycle

    Read across this table, the pattern is consistent: platform and process harmonisation is genuinely moving, while anything requiring cross-institutional culture change — EDI assurance, REF cost reduction, university-level delegation — is progressing far more slowly than the funder-side technical work.

    Common questions on the Tickell review and UKRI reform

    What was the Tickell review of research bureaucracy?

    The Tickell review was an independent UK government review, led by Professor Adam Tickell, examining how research bureaucracy builds up across funders, universities and government. Launched in March 2021, it reported in July 2022 and the government published its formal response on 9 February 2024, setting out reforms for UKRI and the wider sector to implement.

    Has UKRI actually reduced research bureaucracy?

    Partially. UKRI’s 2025–2027 Corporate Plan confirms delivery of a new back-office platform, standardised Funding Service application processes, and harmonised costing rates. However, targets such as two-month faster grant processing are still described as experiments to be demonstrated, not completed reforms, as of 2026.

    What is the UKRI Funding Service?

    The UKRI Funding Service is the single digital platform replacing legacy, council-specific application systems across UKRI’s seven research councils, Innovate UK and Research England. It applies consistent question sets, removes unnecessary attachments, and is UKRI’s primary vehicle for delivering Tickell review commitments on simplified applications.

    Is Researchfish being phased out?

    No — not as of the 2025 to 2027 Corporate Plan. Despite 2024 signals that Researchfish might be phased out, UKRI’s latest plan commits instead to retendering the outcomes-collection system and evolving its performance reporting framework, a materially different path from full replacement.

    What this means for research administrators

    For institutional research offices, the practical implication is sequencing, not completion. Funding Service standardisation and harmonised FEC rates directly reduce per-application administrative effort now; grant-management flexibility, faster peer review, and REF cost reduction remain multi-year commitments to track rather than assume delivered. Institutions engaging via ARMA and BRRIN have the clearest visibility into which workstreams are genuinely moving.

    Given the retendering of Researchfish and continued EDI ambiguity, research administrators should treat UKRI’s Corporate Plan Update as a live delivery tracker rather than a closed case: several 2024 government-response commitments have already shifted in scope by 2026, and further revision before the next Corporate Plan cycle is likely.

    CASRAI’s research administration resources track how funder-level process reform intersects with contributorship, provenance and reporting standards that institutions must still satisfy even as bureaucracy is streamlined.

  • OMB Publication Cost Ban vs the Nelson Memo: What to Negotiate Before October 2026

    The OMB publication cost ban is a proposed revision to 2 CFR 200.461, published in the Federal Register on 29 May 2026, that would make article processing charges (APCs), page charges and colour-figure fees categorically unallowable on federal research awards unless a project specifically budgets and pre-approves them. It arrives while the Nelson Memo’s zero-embargo mandate still requires the same federally funded researchers to make their papers immediately, freely available — a collision research offices need to plan for now, not after the 1 October 2026 effective date.

    In plain terms, the OMB publication cost ban is a default-flip: where 2 CFR 200.461 today allows publication costs as “necessary for the performance of the Federal award,” OMB’s proposed rule presumes them unallowable unless a federal statute requires otherwise or the awarding agency approves them case by case.

    What does the proposed 2 CFR 200.461 rule actually change?

    The Office of Management and Budget’s Notice of Proposed Rulemaking, “Regulation for Federal Financial Assistance” (Federal Register, 29 May 2026, docket 2026-10817), rewrites large sections of the Uniform Guidance in 2 CFR Part 200, including a reversal of §200.461’s default treatment of publication costs.

    Today, publication and printing costs — including APCs at open-access journals and page or colour-figure charges at hybrid titles — are allowable when they report on federally supported work and are levied impartially. Under the proposed text, APCs and “similar fees such as open access fees for professional journal publications” become unallowable except where federal law compels payment or the agency grants case-by-case approval. Comments were due 13 July 2026, though the Council on Governmental Relations has requested an extension; the rule, if finalised as drafted, takes effect 1 October 2026.

    Two consequences follow directly. First, publication spending long absorbed informally into supplies budgets must become an explicit, pre-approved line item at award time. Second, the same NPRM proposes restricting §200.454, which today makes “subscriptions to business, professional, and technical periodicals” allowable; the revised text adds academic periodicals to the unallowable list, though Authors Alliance’s analysis of the NPRM notes it remains genuinely unclear whether OMB intends this to reach institutional library budgets or only project-specific subscriptions.

    How does the ban collide with the Nelson Memo’s zero-embargo mandate?

    The Nelson Memo is the August 2022 Office of Science and Technology Policy directive, “Ensuring Free, Immediate, and Equitable Access to Federally Funded Research,” which instructed every federal agency funding at least $100 million in research and development to eliminate the optional 12-month embargo on peer-reviewed manuscripts and data. Agency policies implementing that directive — including NIH’s revised Public Access Policy (NOT-OD-25-047) and NSF’s public access policy update (PRPD-25-001) — took effect largely across 2024 and 2025, and now require immediate deposit of the accepted manuscript with no embargo period.

    The Nelson Memo did not treat compliance as costless. It explicitly directed agencies to allow researchers to include reasonable publication costs as allowable expenses in research budgets — the same cost category §200.461 would now presume unallowable. Immediate open access is typically achieved one of three ways: paying an APC for gold open access, depositing the manuscript under green open access, or paying through an institutional transformative (read-and-publish) agreement. The proposed rule directly restricts the first route, is largely neutral toward the second, and creates real ambiguity for the third, since indirect-cost-funded transformative agreements do not fit naturally into case-by-case, award-level pre-approval.

    One provision is conspicuously untouched: the federal purpose licence at 2 CFR 200.315(b) — the legal mechanism agencies use to deposit grant-funded manuscripts in public-access repositories — remains in the proposed text as drafted. The legal basis for zero-embargo repository deposit survives even as the funding route for paid open access narrows. Institutions cannot assume the mandate will soften just because the money is harder to find.

    What happens to subscriptions, transformative deals and the international picture?

    Read-and-publish agreements sit awkwardly across both proposed changes. Universities that have negotiated these deals typically bundle subscription access and OA publishing rights into a single institutional payment, usually drawn from the indirect cost pool rather than itemised per article. If §200.454’s subscription restriction is read to include institutional library subscriptions, and §200.461’s APC restriction is read to include the OA-publishing component of transformative deals, the combined effect could touch both halves of a single contract — without either provision naming transformative agreements directly.

    The US retreat looks unusual against comparable funder policy elsewhere. UKRI and Horizon Europe’s cOAlition S signatories already fund publication costs directly through block grants or eligible-cost provisions, because their zero-embargo mandates presuppose a funding route. For a collaboration with a US subrecipient and non-US lead institution, that divergence determines which partner’s budget can legally absorb the APC.

    Funder / jurisdiction Zero-embargo OA requirement Publication cost funding stance
    US federal agencies (NIH, NSF, DOE, USDA) under the Nelson Memo Yes — immediate deposit, no embargo Proposed 2 CFR 200.461 would make APCs presumptively unallowable absent pre-approval
    UKRI (UK) Yes — immediate OA required for most outputs Block grants and in-scope grant costs explicitly fund APCs
    Horizon Europe / cOAlition S signatories Yes — Plan S zero-embargo principle APCs treated as eligible project costs where OA is mandated

    Offices administering joint US–UK or US–EU awards should treat this as a live compliance risk: the same paper may need immediate deposit under one funder’s rules while its lead US institution can no longer legally pay the APC that made deposit unnecessary.

    What should research offices negotiate before October 2026?

    Institutions have a narrow window before the effective date:

    • Budget publication costs explicitly. Awards dated after 1 October 2026 should carry a named, pre-approved publication line item rather than relying on discretionary reallocation later.
    • Clarify transformative agreement language. Confirm with publishers, in writing, whether institutional payments are classified as subscription or publication costs, since §200.461 reaches the substance of a payment, not its label.
    • Document green open access workflows. Since the federal purpose licence under 2 CFR 200.315(b) is unaffected, manuscript deposit to agency repositories remains the most audit-resistant compliance path.
    • Submit substantive comments. Comments citing the Nelson Memo, NOT-OD-25-047 and PRPD-25-001 by name, documenting the operational conflict directly, carry more weight than generic objections.
    • Map multi-funder awards. Offices running US–UK or US–EU collaborations should flag which funder’s rules govern publication costs before submission, not at closeout.

    Answer-first: quick questions on publication costs

    Who pays for publication fees?

    Publication fees are typically paid by the author’s research funder, their institution, or the author directly. Under current US federal rules, grant funds routinely cover APCs; the proposed 2 CFR 200.461 revision would shift that burden onto institutions unless a project specifically budgets for it in advance.

    How much does it cost to publish in open access?

    Article processing charges vary widely by publisher and journal tier, from no charge at diamond open-access titles to several thousand dollars at flagship journals. The figure depends on venue, not funder — which is why offices need a pre-approved, venue-agnostic publication budget line rather than a fixed assumption.

    Why are article processing charges so high?

    Article processing charges reflect editorial, peer-review and production costs plus, at prestigious titles, a reputation premium. Because funders rather than competitive pricing pressure have historically absorbed these charges, journals have had limited incentive to reduce them.

    Implications and outlook

    The contradiction between a rule that bans paying for open access and a mandate that requires it will not resolve itself quietly. Litigation, a revised final rule, or an OMB clarification narrowing “case-by-case” to budget-level rather than publication-level approval are all plausible before 1 October 2026. What is not plausible is that either policy simply disappears: the Nelson Memo’s zero-embargo requirement is embedded in agency policy notices already in force, and the OMB rewrite proceeds under Congress’s grant of authority at 31 U.S.C. 503.

    For research administration offices, the safest posture treats the coming months as a negotiation window, not a waiting period: secure pre-approved publication lines, harden green open-access workflows under the still-intact federal purpose licence, and map which funder’s cost rules govern each collaborative output. Institutions doing that work now will keep publishing compliantly under both regimes; those waiting for the contradiction to resolve will inherit the audit findings meanwhile.

  • Immigration Skills Charge 2026: 9 Exempt Research Roles

    The Immigration Skills Charge rose 32% for Certificates of Sponsorship assigned from 16 December 2025, taking the standard rate to £1,320 per worker per year (£480 for small and charitable sponsors). But under the Immigration Skills Charge (Amendment) Regulations 2025 (SI 2025/1078), nine research-science and higher-education occupation codes remain fully exempt — meaning most university researchers sponsored on the Skilled Worker visa pay nothing towards the increase.

    The Immigration Skills Charge (ISC) is a mandatory Home Office levy paid by UK employers each time they assign a Certificate of Sponsorship to a Skilled Worker or Senior or Specialist Worker visa applicant, unless a statutory exemption applies. For sponsor-licence holders in the higher education and research sector, the practical question raised by the December 2025 rise is not “how much more will this cost” but “does this cost apply to us at all” — and for most academic and research posts, the answer is no.

    What changed: the 2026 Immigration Skills Charge increase

    The ISC increase took effect for Certificates of Sponsorship (CoS) assigned on or after 16 December 2025, under the Immigration Skills Charge (Amendment) Regulations 2025 (SI 2025/1078). The rise was first flagged in the government’s 2025 Immigration White Paper and implemented via secondary legislation rather than primary reform, which is why it applied with limited notice mid-financial-year for most institutions.

    The rates rose as follows:

    Sponsor type Rate to 15 Dec 2025 Rate from 16 Dec 2025 Additional 6-month block
    Medium or large sponsor £1,000 / 12 months £1,320 / 12 months £660 (up from £500)
    Small or charitable sponsor £364 / 12 months £480 / 12 months £240 (up from £182)

    A UK Parliament research briefing (CBP-9859, February 2026) confirms the 32% ISC uplift and notes that individual Certificate of Sponsorship fees rose by 120% in the same period, to £525. Wider Home Office immigration and nationality fees — including Indefinite Leave to Remain, which rose from £3,029 to £3,226 — increased again from 8 April 2026, typically by 6–7%. Sponsors must budget for these as separate, cumulative costs alongside the ISC.

    Which occupation codes are exempt from the ISC?

    Regulation 4 of the Immigration Skills Charge Regulations 2017, as amended by SI 2025/1078, exempts specific Standard Occupational Classification (SOC 2020) codes listed in the Home Office’s Appendix Skilled Occupations. Nine of these correspond directly to research and higher-education roles.

    SOC code Occupation ISC status
    2111 Chemical scientists Exempt
    2112 Biological scientists Exempt
    2113 Biochemists and biomedical scientists Exempt
    2114 Physical scientists Exempt
    2115 Social and humanities scientists Exempt
    2119 Natural and social science professionals n.e.c. Exempt
    2161 Research and development managers Exempt
    2162 Other researchers, unspecified discipline Exempt
    2311 Higher education teaching professionals Exempt

    Three further non-academic codes — clergy (2463), sports players (3431) and sports coaches, instructors and officials (3432) — are also exempt under the same regulation, reflecting the same “acute domestic skills shortage” rationale that underpins the research exemptions rather than any HE-specific carve-out.

    Two further exemption routes matter for universities specifically:

    • Health and Care Worker visa roles are exempt under Regulation 4(2)(d), relevant to university-linked NHS and clinical academic appointments.
    • Student-to-Skilled-Worker switchers applying from inside the UK are exempt, covering the common pathway of PhD graduates moving into postdoctoral posts with the same or a new sponsor.

    Which university and R&D roles still have to pay?

    The exemption list is narrow and code-specific — it does not cover the full range of roles a university sponsors. Professional services, technical and administrative staff sponsored under non-exempt SOC codes pay the full increased ISC, even where they support research directly.

    Role type Typical SOC code ISC payable?
    Principal investigator / academic researcher 2161, 2162, 2111–2119 No
    Lecturer / higher education teaching professional 2311 No
    Research software engineer / data scientist 2136, 2425 Yes
    Research administrator or grants manager 2422, 4159 Yes
    University registrar / senior administrator 2317 Yes
    Laboratory technician 2141, 3111 Yes

    This distinction matters for institutional budgeting. A university sponsoring a chemistry professor and a research software engineer on the same grant will pay the full £1,320 (or £480) charge for the latter but nothing for the former — a gap that widens further on multi-year CoS periods, where the charge compounds in six-month blocks.

    How do sponsors evidence an ISC exemption to UKVI?

    Exemption is not automatic in the sense of requiring no action: the Sponsorship Management System calculates the charge based on the SOC code entered when the CoS is assigned, so accuracy at that point is what determines whether the exemption applies. Getting the occupation code wrong — or defaulting to a broader “researcher-adjacent” code that is not on the exempt list — triggers a top-up demand and, on audit, can be treated as a compliance failure rather than a simple correction.

    • Confirm the exact SOC 2020 code against the current Appendix Skilled Occupations before assigning the CoS — codes are amended periodically and the exempt list is not identical to the eligible-occupations list.
    • Retain the job description, person specification and salary evidence used to justify the code, in case UKVI queries the classification during a sponsor licence audit.
    • Do not assume seniority implies exemption: a senior professional-services manager on a high salary is not exempt merely because the role is research-adjacent or PhD-preferred.
    • Where a worker changes role within the same institution, reassess the SOC code and ISC liability for the new Certificate of Sponsorship — exemption status is not inherited from a prior post.

    For research administration teams managing sponsor licence compliance, this makes SOC-code governance — not just cost forecasting — the operationally critical task created by the December 2025 change.

    Frequently asked questions

    Has the immigration skills charge gone up?

    Yes. The ISC rose 32% for Certificates of Sponsorship assigned from 16 December 2025, under the Immigration Skills Charge (Amendment) Regulations 2025 (SI 2025/1078). The large-sponsor rate increased from £1,000 to £1,320 per worker per year, and the small/charitable rate from £364 to £480.

    Are immigration fees going up in 2026?

    Yes, separately from the ISC. Most Home Office immigration and nationality fees rose again from 8 April 2026, typically by 6–7%, including the Indefinite Leave to Remain fee moving from £3,029 to £3,226. Sponsors should treat the ISC rise and this later fee round as two distinct, cumulative cost events.

    How much is the UK visa fee for 2026?

    Visa sponsorship cost is layered: alongside the ISC (£1,320 or £480), sponsors typically also pay a £525 Certificate of Sponsorship fee, the worker’s visa application fee, and the Immigration Health Surcharge — each governed by separate, independently updated fee schedules.

    What this means for sponsor licence compliance

    For most UK universities, the practical budget impact of the December 2025 ISC rise falls on professional services, technical and non-exempt research-support hires rather than on core academic and research appointments. That makes SOC-code accuracy — checked against the current Appendix Skilled Occupations at the point each CoS is assigned — a higher-value compliance control than headline cost forecasting alone.

    Institutions running multi-year, multi-worker sponsorship programmes should audit their occupation-code mapping now: misclassifying an exempt research post under a chargeable administrative code (or vice versa) creates either avoidable cost or exposure to a UKVI top-up demand and audit finding. As Home Office fee schedules continue to move on separate timetables — ISC in December, general fees in April — sponsor licence holders in the research sector gain the most by tracking SOC-code exemption status as a standing compliance item, not a one-off check at the time of the 2025 increase.

  • NIH Public Access Policy 2026: Zero-Embargo Mandate

    The NIH Public Access Policy in 2026 requires that final peer-reviewed manuscripts from NIH-funded research be deposited in PubMed Central and made publicly available on the same day the article is published, with no embargo period. One year after this zero-embargo mandate took effect on 1 July 2025, the US Government Accountability Office has warned that meeting it could push federal publishing costs toward $1 billion a year by 2030.

    The NIH Public Access Policy is the National Institutes of Health’s requirement that peer-reviewed manuscripts arising in whole or in part from NIH funding be archived in PubMed Central (PMC) and made freely available to the public, without a subscription paywall or embargo delay, from the official date of publication.

    What is the NIH Public Access Policy in 2026?

    The current policy traces to a 2022 memorandum from the White House Office of Science and Technology Policy (OSTP), commonly known as the Nelson Memo after then-OSTP Director Alondra Nelson, which directed federal agencies to remove embargoes on the results of taxpayer-funded research. NIH’s implementation — the 2024 NIH Public Access Policy — took effect for manuscripts accepted for publication on or after 1 July 2025.

    The policy applies to any journal-accepted manuscript resulting from NIH funding through a grant, cooperative agreement, contract, Other Transaction, or intramural research, regardless of whether the NIH-funded investigator is the corresponding author. Authors must retain the right to deposit their author accepted manuscript (AAM) in PMC by asserting the NIH Rights Statement in publication agreements, and NIH holds a nonexclusive Government Use License under 2 CFR 200.315 that survives any later exclusive-rights agreement signed with a publisher.

    What changed under the zero-embargo mandate?

    The defining change from the prior 2008 policy is timing, not scope. Under the 2008 rule, authors had up to twelve months after publication to make their manuscript public and up to 90 days to supply a PMCID. Under the 2024 policy, the manuscript must be publicly available in PMC on the official date of publication, with no embargo window at all.

    Requirement 2008 Policy 2024 Policy (effective 1 July 2025)
    Embargo before public availability Up to 12 months None — available on official date of publication
    Evidence of compliance PMCID within 90 days PMCID immediately, or a temporary NIHMSID for up to 3 months
    Deposit trigger Upon acceptance Upon acceptance (unchanged)
    Repository PubMed Central PubMed Central (unchanged)

    Compliance remains an institutional responsibility. Failure to demonstrate compliance in an application, proposal or progress report is a violation of NIH award terms and can delay non-competing continuation funding.

    What did GAO’s May 2026 report find?

    On 21 May 2026, the Government Accountability Office published GAO-26-107738, examining whether selected federal agencies’ public access plans are consistent with OSTP guidance and how much compliance is costing the government. As reported by MedPage Today, GAO estimated that combined federal publishing charges could climb to roughly $1 billion a year by 2030 — about triple the $295 million agencies were paying in the recent baseline year the report examined.

    GAO’s central finding is that zero-embargo compliance is increasingly routed through paid open-access publishing rather than free green open-access deposit, because many subscription journals will not grant immediate PMC deposit rights on standard terms. SPARC’s 22 May 2026 statement on the report pushed back on that framing, arguing that pay-to-publish models remain optional and that the underlying NIH policy itself imposes no fee — authors can comply at zero cost by depositing the author accepted manuscript directly.

    NIH has already begun responding to the cost pressure. Its December 2024 guidance, NOT-OD-25-048, set out what publication costs are allowable and reasonable under NIH awards, and the agency has signalled a cap on allowable publication costs starting in fiscal year 2026 — a direct answer to the “who pays for zero embargo” question GAO’s report puts back on the table.

    How should institutions adjust compliance workflows?

    For research offices, the practical burden of zero embargo has shifted from a single post-acceptance reminder to a submission-stage decision point. Institutions that have adapted their workflows are typically doing the following:

    • Requiring the NIH Rights Statement be inserted into every manuscript submitted for peer review before a publication agreement is signed.
    • Maintaining a tracked list of publishers’ zero-embargo green open-access terms, following the model of library-maintained trackers such as Northwestern’s Galter Health Sciences Library publisher guide.
    • Budgeting article processing charges into grant proposals where a subscription journal will not permit immediate deposit, rather than absorbing the cost after acceptance.
    • Negotiating or expanding “Read and Publish” agreements with major publishers to reduce per-article APC exposure.
    • Monitoring NIH’s allowable-cost guidance (NOT-OD-25-048) and the incoming FY2026 publication-cost cap for changes to what can be charged to an award.

    Institutions should treat the AAM-deposit route as the default compliance path and reserve APC-funded open access for cases where a publisher genuinely will not permit zero-embargo green deposit — this keeps compliance costs closest to the $0 the underlying policy actually requires, even as GAO’s figures show the system-wide trend running the other way.

    Common questions about the NIH Public Access Policy

    What is the NIH Public Access Policy?

    It is NIH’s requirement that peer-reviewed manuscripts resulting from NIH funding be deposited in PubMed Central and made publicly available without a paywall. The 2024 version, in force since 1 July 2025, removed the prior 12-month embargo entirely.

    When did the NIH zero-embargo policy take effect?

    The zero-embargo requirement applies to manuscripts accepted for publication on or after 1 July 2025. Manuscripts accepted before that date remain subject to the 2008 policy’s 12-month embargo and 90-day PMCID rule.

    Does the NIH Public Access Policy require paying an article processing charge?

    No. Authors can comply at zero cost by depositing the author accepted manuscript directly in PubMed Central. Costs arise only when a subscription publisher refuses immediate green deposit and pushes the author toward a paid open-access route.

    What did the GAO report say about NIH public access costs?

    GAO-26-107738, published 21 May 2026, found that federal publishing costs tied to public access compliance could approach $1 billion annually by 2030, and questioned whether agencies’ plans consistently follow OSTP guidance.

    What this means going into year two

    Year two of the mandate is less about awareness — most NIH-funded institutions now understand the mechanics — and more about cost governance. GAO’s report gives research administrators a federal-level evidence base for what many libraries had already observed anecdotally: that publishers control the compliance pathway, and default routing toward APCs is a policy design risk, not an inevitability. Institutions that formalise submission-stage checks and lean on the free AAM-deposit route, rather than treating open-access APCs as the default fix, are best placed to keep both their researchers compliant and their grant budgets intact as NIH’s own cost caps take shape through fiscal year 2026.

    Research administrators tracking related funder mandates and contributor standards can find further research administration compliance guidance on CASRAI’s site.

  • NSPM-33 Certification Deadlines by Agency

    There is no single NSPM-33 research security program certification deadline. Under National Security Presidential Memorandum-33, each federal funding agency issues its own implementation policy on its own timetable, then gives covered institutions up to 18 months to certify compliance. The result is a staggered set of dates running from the National Institutes of Health’s 25 May 2026 training cut-off to NASA’s 5 August 2026 implementation date, with cybersecurity-programme certification already expected by some sponsors as early as 1 July 2026.

    NSPM-33 is the 2021 presidential directive that requires US federal research agencies, and the institutions receiving more than $50 million a year in federal research funding from them, to establish research security programs covering cybersecurity, foreign travel security, research security training and export-control training.

    Why NSPM-33 has no single certification deadline

    The White House Office of Science and Technology Policy (OSTP) issued its Guidelines for Research Security Programs at Covered Institutions on 9 July 2024. That memo set a common four-part framework — cybersecurity, foreign travel security, research security training and export-control training — but left the timing of implementation to each funding agency individually.

    Each agency must translate the OSTP framework into its own binding policy, and covered institutions then have up to 18 months from that agency’s effective date to implement and certify compliance. Because agencies have finalised their policies at different points between 2025 and 2026, the resulting certification deadlines are sponsor-specific rather than uniform.

    • A policy effective 1 May 2025 produces a certification deadline around 1 November 2026.
    • A policy effective 25 May 2026 (NIH’s training requirement) produces a certification deadline extending into late 2027.
    • A policy not yet finalised (the Department of Defense, as of mid-2026) has no computable deadline at all.

    Institutional compliance memos that cite a single “July 2026” deadline are typically describing one illustrative 18-month calculation, not a government-wide cut-off date.

    Agency-by-agency NSPM-33 deadlines

    The table below sets out the confirmed research security training and certification effective dates by agency, as published in each agency’s own notices. These are training and certification effective dates, not the full 18-month research security program certification deadline, which is calculated separately per agency.

    Agency Requirement Effective date Source
    Department of Energy (DOE) Research security training (RST) certification 1 May 2025 DOE Research Security Training Requirement notice
    National Science Foundation (NSF) RST certification for senior/key personnel 2 December 2025 NSF Important Notice No. 149
    US Department of Agriculture (USDA) RST certification, annual recertification 31 December 2025 USDA General Terms and Conditions for Federal Awards, 2025
    National Institutes of Health (NIH) Other Support disclosure training 1 October 2025 NIH Notice NOT-OD-25-133
    National Institutes of Health (NIH) RST certification for applications due on/after this date 25 May 2026 NIH Notice NOT-OD-26-017
    NASA RST and certification for new proposals and awards 5 August 2026 NASA Grant Information Circular 26-02
    Department of Defense (DOD) RST and certification Not yet finalised (anticipated late 2026) Agency research security notices, pending

    A frequent error in institutional planning documents is attributing NASA’s 5 August 2026 date to DOE, or treating it as a government-wide cybersecurity deadline. DOE’s own RST requirement took effect over a year earlier, on 1 May 2025 — the two dates govern different agencies entirely and should never be merged into one calendar entry.

    Cybersecurity certification and the Malign Foreign Talent Recruitment Program

    Cybersecurity is one of the four mandatory pillars of an OSTP-compliant research security program, alongside foreign travel security, research security training and export-control training. Several research offices, including the University of Wisconsin–Madison’s, have told federally funded investigators that cybersecurity-programme assessments and certification will be required for some sponsors as soon as 1 July 2026 — making it, for those institutions, the earliest of the four pillars to bind.

    Separately, and already in force, is the Malign Foreign Talent Recruitment Program (MFTRP) certification created under Section 10632 of the CHIPS and Science Act of 2022. This requires applicant organisations to certify that no covered individual listed on a federal research award is a party to a malign foreign talent recruitment programme contract. Unlike the training deadlines above, MFTRP certification is not a future 2026 milestone — it has applied to covered federal grant applications for several award cycles and predates most agencies’ research security training rollouts.

    Conflating the MFTRP certification (already active), the research security training deadlines (rolling out 2025–2026), and the full 18-month research security program certification (staggered into 2027) is the single most common source of confusion in institutional compliance planning.

    Frequently asked questions

    What is the NSPM-33 policy?

    NSPM-33 is a National Security Presidential Memorandum that directs federal research agencies to standardise disclosure requirements and require covered institutions — those receiving more than $50 million a year in federal research funding — to establish research security programs addressing cybersecurity, travel security, training and export controls.

    Is there a single NSPM-33 certification deadline for all institutions?

    No. Each federal agency sets its own effective date and then allows covered institutions up to 18 months to certify compliance. Because agencies finalise policies at different times, certification deadlines are sponsor-specific and range from mid-2026 into 2027, not a single government-wide date.

    When must NIH-funded researchers complete research security training?

    Under NIH Notice NOT-OD-26-017, research security training and the associated individual and institutional certifications apply to applications with due dates on or after 25 May 2026. Personnel who completed training more than 12 months earlier must take a refresher before that date.

    What is the Malign Foreign Talent Recruitment Program certification requirement?

    The Malign Foreign Talent Recruitment Program (MFTRP) certification, created by Section 10632 of the CHIPS and Science Act, requires applicant institutions to certify that no covered individual on a federal award is party to a malign foreign talent recruitment contract. It is already active and distinct from the newer, staggered research security training deadlines.

    Implications for research administrators

    Treating NSPM-33 as a single deadline creates two opposite risks: institutions that harmonise everything to the earliest date (1 May 2025 for DOE, or 1 July 2026 for cybersecurity) risk imposing sponsor-specific controls on researchers who do not need them; institutions that wait for one government-wide date risk missing a sponsor’s actual certification window and exposing themselves to False Claims Act liability, sponsor audits, or loss of funding eligibility.

    Research administration offices should instead build and maintain a deadline matrix that records, per sponsor: the agency’s published effective date, the computed 18-month certification deadline, and interlocking dates such as MFTRP certification points and common-disclosure-form adoption. Reviewing this matrix against each agency’s own notices — DOE, NSF, USDA, NIH, NASA and, once published, DOD — is the only reliable way to track NSPM-33 compliance, and it sits alongside the broader set of research administration compliance obligations that institutions must already coordinate across sponsors.

    As the Department of Defense and remaining agencies finalise their policies through the rest of 2026, expect the spread of certification deadlines to widen further into 2027 rather than converge on a single date. Institutions that keep a sponsor-by-sponsor matrix, rather than a single calendar entry, will be the ones that pass sponsor audits without last-minute scrambling.

  • Malign Foreign Talent Recruitment Program Guide to NSPM-33 Disclosure

    A malign foreign talent recruitment program (MFTRP) is any position, programme, or activity sponsored by a “country of concern” — currently China, Russia, North Korea, or Iran — that offers a US federally funded researcher compensation in exchange for undisclosed intellectual property transfer, secrecy, or duplicative work. Under National Security Presidential Memorandum 33 (NSPM-33), every federal grant applicant and covered individual must disclose current and pending foreign affiliations and certify non-participation before an award is made, and research offices must build a certification chain to collect, verify, and renew those disclosures annually.

    A foreign talent recruitment programme is any initiative — funded or unfunded — through which a foreign government or foreign entity recruits science and technology professionals. It becomes “malign” only when it is sponsored by a designated country of concern and involves one or more prohibited practices defined in US law. This distinction matters: not every international collaboration is malign, but every disclosure obligation under NSPM-33 hinges on getting that distinction right.

    What is a malign foreign talent recruitment program?

    A malign foreign talent recruitment program is a legally defined category, not a colloquial label. Under 42 U.S.C. § 19237 — enacted through the CHIPS and Science Act (Public Law 117-167, 2022) — a foreign talent recruitment programme crosses into “malign” territory when it is organised, managed, or funded by a country of concern and requires the participant to do one or more of the following:

    • Transfer intellectual property, data, or non-public research materials without authorisation
    • Recruit other trainees or researchers into the programme
    • Establish a lab, company, or accept a faculty post abroad in a way that conflicts with a US federal award
    • Conceal the affiliation from their US employer or federal funding agency
    • File patents in the foreign country ahead of, or instead of, the United States
    • Accept a contract that is extraordinarily difficult to terminate

    The four designated countries of concern — China (including Hong Kong and Macau), Russia, North Korea, and Iran — were fixed as of 1 January 2024 under the statutory definitions at 15 U.S.C. § 3371. Ordinary international co-authorship, visiting fellowships, or honorary titles are not malign unless they meet this test.

    What does NSPM-33 actually require, and where does it come from?

    NSPM-33 is the January 2021 presidential directive requiring federal research agencies to standardise disclosure of researchers’ foreign affiliations, funding, and support in order to protect federally funded research from undisclosed foreign government influence. The White House Office of Science and Technology Policy (OSTP) issued implementing guidance in January 2022, and individual agencies — NSF, DoD, NIH, DOE, and others — have since translated that guidance into agency-specific forms and certification requirements.

    Two structural obligations sit underneath the disclosure rules. First, every covered individual named on a proposal — principal investigators, co-PIs, and other senior/key personnel — must certify that their disclosures are accurate, current, and complete. Second, institutions receiving more than $50 million per year in federal research funding must operate a formal research security programme covering cybersecurity, foreign travel security, insider-threat awareness, and export-control training, per NSPM-33’s implementation guidance.

    What must applicants disclose, and on which forms?

    Disclosure obligations attach to the biographical sketch and the current-and-pending-support (or “other support”) sections of a proposal. Applicants must list every professional, scientific, and academic appointment or affiliation, whether or not it is remunerated, plus all current and pending research support — foreign and domestic — including in-kind contributions such as lab space, equipment, or staff time. Agencies have not converged on a single form, which is itself an operational risk for multi-agency research offices:

    Agency Disclosure vehicle Certification requirement
    National Science Foundation (NSF) NSF Biographical Sketch and Current & Pending Support Annual certification of non-participation for PIs and co-PIs (from May 2025 policy update)
    Department of Defense (DoD) SF 424 (research and related senior/key person profile) Certification at time of proposal submission
    National Institutes of Health (NIH) Other Support format page Disclosure of foreign components and affiliations at submission and just-in-time
    Department of Energy (DOE) Agency-specific certification per award terms Outright prohibition on participation for funded personnel

    The lack of a single harmonised form means a research office supporting investigators across NSF, DoD, NIH, and DOE portfolios must track four separate certification pathways rather than one — a genuine administrative burden that NSPM-33’s “standardisation” goal has not yet fully resolved in practice.

    How do research offices build the institutional certification chain?

    Individual researcher honesty is necessary but not sufficient. NSPM-33 compliance depends on an institutional process that verifies, documents, and renews disclosures across the life of an award. A defensible certification chain has five links:

    1. Intake: capture foreign affiliations, funding, and appointments from every covered individual at proposal stage, not just the PI
    2. Screening: test each affiliation against the country-of-concern list and the prohibited-practices criteria before certification is signed
    3. Institutional certification: the applicant organisation certifies that every covered individual has been made aware of the disclosure requirements — a distinct obligation from the individual’s own certification
    4. Ongoing reporting: new MFTRP participation discovered during an award must typically be reported within 30 days, and new project participants must complete disclosure before starting work
    5. Annual renewal: re-certify non-participation and refresh mandatory research security training (NSF’s training requirement renews every three years)

    Non-US institutions receiving US federal subawards face the same chain. The University of Cambridge’s research services office, for example, operates a documented procedure requiring initial disclosure at proposal submission, annual re-certification for the life of the award, and mandatory NSF Research Security Training for all covered individuals — evidence that the certification chain is now an international compliance requirement, not a US-only administrative artefact.

    Consequences for non-compliance are not theoretical. Participation in an MFTRP, once identified, is typically treated as cause for immediate dismissal from federally sponsored proposals or awards, alongside potential civil or criminal penalties under the same statutory framework.

    Answer-first Q&A

    What is a malign foreign talent recruitment program?

    It is a foreign-government-sponsored programme, position, or activity that offers a researcher compensation — cash, in-kind funding, travel, or honorific titles — in exchange for conduct such as undisclosed IP transfer, secrecy about the affiliation, or duplicative work that conflicts with a US federal research award.

    Which countries are currently identified as having malign foreign talent recruitment programs?

    As of 1 January 2024, US law designates four countries of concern under 15 U.S.C. § 3371: China (including Hong Kong and Macau), Russia, North Korea, and Iran. Only programmes sponsored by, or affiliated with, entities in these jurisdictions can meet the statutory definition of “malign.”

    What are foreign talent recruitment programs?

    A foreign talent recruitment programme, in the general (non-malign) sense, is any initiative — funded or unfunded — through which a foreign government or institution recruits science and technology professionals or students. Most are legitimate; a programme only becomes reportable as malign when it meets the country-of-concern and prohibited-practices tests above.

    What is a talent recruitment program?

    Distinct from MFTRPs, a “talent program” in the US federal HR context (via USAJobs) is a domestic hiring pathway connecting vetted candidates to federal agencies — unrelated to foreign-government recruitment. Research offices should avoid conflating the two terms when training investigators, since the compliance obligations differ entirely.

    Implications for research administrators

    NSPM-33 shifted foreign-influence disclosure from an informal conflict-of-interest question into a codified, cross-agency certification requirement with statutory teeth. For research administrators, the practical task is no longer whether to ask about foreign affiliations, but how to standardise intake across agency-specific forms, screen consistently against the four-country list and nine prohibited practices, and keep certifications current through 30-day reporting windows and annual renewals. Institutions that treat this as a one-time proposal-stage checkbox — rather than a maintained certification chain spanning the full award lifecycle — carry the greatest compliance exposure as agencies tighten enforcement through 2026 and beyond.

    Research offices building or auditing this workflow may find it useful to situate MFTRP disclosure within the broader landscape of research administration compliance frameworks, where foreign-influence certification now sits alongside conflict-of-interest and conflict-of-commitment disclosure as a standard pre-award control.

  • FORCE11 Scholarly Communication Institute 2026: A Career Pathway for Research-Support Staff

    The FORCE11 Scholarly Communication Institute (FSCI) is an annual week-long summer training programme, co-hosted by FORCE11 and the UCLA Library, that teaches researchers, librarians, publishers, funders, and research administrators the practical skills of open scholarly communication. For research-support professionals specifically, FSCI functions less like a one-off conference and more like a structured training pathway: a recognised route to build open-science, data-stewardship, and research-metrics competence that can be cited on a CV or used to justify a promotion case. FSCI 2026 runs 27–31 July 2026.

    The FORCE11 Scholarly Communication Institute is best defined this way: it is a volunteer-run, multi-day summer school in which attendees select one week-long “morning course” plus a rotation of shorter afternoon electives covering topics such as FAIR data stewardship, persistent identifiers, peer review, and research metrics. It was first launched in 2017 and is modelled on the longer-running Digital Humanities Summer Institute in Victoria, British Columbia.

    What is the FORCE11 Scholarly Communication Institute?

    FSCI is the training arm of FORCE11, the community that originated in 2011 around “the Future of Research Communications and e-Scholarship.” Since 2017, FSCI has been co-organised with the UCLA Library and runs each summer, alternating in recent years between in-person, online, and hybrid formats. Course materials from FSCI 2020 through FSCI 2024 have been archived openly on Zenodo and the Open Science Framework, so the institute leaves a durable, citable training record rather than a one-time event.

    FORCE11’s broader track record matters for credibility: the same community co-developed the FAIR Data Principles and the Joint Declaration of Data Citation Principles, two frameworks that underpin research-data policy at funders and repositories worldwide. FSCI teaches practitioners to apply that same body of work operationally, rather than simply reading about it.

    Who should attend FSCI as a career-development step?

    FSCI is explicitly multi-audience: researchers, librarians, publishers, funders, university research-administration staff, students, and postdocs all attend the same institute, choosing courses at introductory or advanced level. For a research-support professional — someone working in a research office, library scholarly-communication unit, or funder programme team — this cross-sector mix is the point.

    Rather than training in isolation with only colleagues from one institution, attendees benchmark their skills against a global peer group. A 2018 Serials Review analysis of the institute (Rodriguez, 2018, DOI: 10.1080/00987913.2018.1555510) described FSCI as training people “not for where we’re at, but for where we’re going” — a framing that positions the institute as anticipatory skills-building rather than remedial catch-up.

    • Research administrators managing open-access compliance or data-management-plan review
    • Library staff moving into or already working in scholarly-communication roles
    • Early-career researchers who want to specialise in research infrastructure rather than bench/field research
    • Funder programme officers who need to understand practitioner-level workflows, not just policy text
    • Publishing and repository staff building peer-review, persistent-identifier, or metrics expertise

    How does the FSCI course structure work?

    Each attendee commits to one week-long morning course, which allows sustained, cohort-based depth on a single subject, and supplements it with shorter afternoon elective courses on adjacent topics. This structure is designed to produce both a depth credential (the morning course) and breadth exposure (the electives), which is unusual among short-format professional development options in the research-support field.

    Topics have included FAIR data management and stewardship, persistent identifiers, peer-review innovation, new forms of publication, research-metrics literacy, and — in recent years — AI governance in scholarly communication. Plenary sessions, “do-a-thons,” and structured networking events run alongside the coursework, which is what distinguishes FSCI from a standard webinar series.

    What does FSCI cost, and are scholarships available?

    FSCI publishes its registration fees and scholarship terms on the official FORCE11 site ahead of each year’s institute, and pricing has varied by year and by in-person/online format. FORCE11 has consistently run a scholarship programme to support attendance from historically underrepresented regions; organisers have reported scholarship recipients from six continents, including documented career-changing participation from institutions in Nigeria and Pakistan. For a research-support professional building a career-development business case, the scholarship route is often the most persuasive argument to an institution reluctant to fund a full-fee place.

    Attribute FSCI (FORCE11) Formal scholarly communication librarian role
    Format One-week intensive summer institute Ongoing salaried position
    Entry route Open registration; no degree prerequisite Typically requires an MLIS or equivalent
    Cost to individual Course fee, offset by scholarships N/A — paid employment
    Output Practical skills, network, open course materials Institutional job title and remit
    Best used as A training pathway feeding into or alongside a role The destination role itself

    How does FSCI differ from a formal scholarly communication librarian role?

    It is worth being precise about the distinction, because the two are often conflated in search results. A scholarly communication librarian is a formal, usually MLIS-qualified, salaried institutional role with responsibilities such as running an institutional repository, advising on copyright and open-access policy, or managing an “office of scholarly communication.” FSCI is not that role — it is a training pathway that can be undertaken by someone already in such a role, by someone aspiring to move into one, or by a research administrator, funder officer, or publisher who never intends to hold that job title at all.

    This distinction matters for career planning. Treating FSCI as a credential-building input — alongside, not instead of, formal qualifications, ORCID-linked professional profiles, and institutional experience — is the more accurate way to use it. Institutions considering whether to fund staff attendance should therefore evaluate FSCI as continuing professional development, comparable to funding attendance at ARMA, NCURA, or EARMA training events, rather than as a substitute for a formal library or research-office qualification.

    Frequently asked questions

    What is FSCI 2026 and when does it take place?

    FSCI 2026 is the annual FORCE11 Scholarly Communication Institute, running 27–31 July 2026. It follows the institute’s established format of a week-long morning course paired with rotating afternoon electives on open-science and research-communication topics for a global, cross-sector audience.

    How much does FORCE11 FSCI cost to attend?

    Registration fees are set and published by FORCE11 for each year’s institute and vary by format and early registration. FORCE11 runs a dedicated scholarship programme that has supported attendees from underrepresented countries and regions, which materially lowers the effective cost for many participants.

    Who should attend the FORCE11 Scholarly Communication Institute?

    FSCI is designed for researchers, librarians, publishers, funders, and research administrators at any career stage, plus students and postdocs. Courses are offered at introductory and advanced levels, so attendees choose a track matched to their existing scholarly-communication knowledge.

    Are FSCI course materials available after the event?

    Yes. FORCE11 has archived FSCI course materials from 2020 through 2024 openly on Zenodo and the Open Science Framework, meaning the training content remains accessible as a reference resource even for people who did not attend that year’s live sessions.

    What this means for research-support careers

    For institutions, FSCI attendance is a low-cost, high-signal way to build in-house open-science capacity without hiring a new specialist role. For individuals, it is a documented, citable training credential that sits alongside — not in place of — formal qualifications and institutional experience. As open-access mandates, data-management requirements, and AI-governance expectations continue to expand across funders including UKRI and cOAlition S signatories, the practical skills FSCI teaches are becoming a standard expectation of research-support work rather than a specialist add-on.

    Research offices, libraries, and funder teams weighing professional-development budgets in 2026 should treat FSCI as one input in a broader research-support career pathway: a way to keep staff current with FAIR data practice, persistent identifiers, and evolving scholarly-communication standards, while formal qualifications and institutional experience continue to do the work of defining the job itself.

  • CRediT Taxonomy Author Contributions Example: Trial Consortia

    A credit taxonomy author contributions example for a 100+-author clinical trial consortium paper typically cannot assign all 14 CRediT roles to every named individual. Instead, most multi-site consortia assign roles to a small “writing committee,” then credit the remaining site investigators and staff as a collective group — a workable but imperfect compromise between transparency and practicality.

    The CRediT taxonomy author contributions example published by most journals — one paper, a handful of authors, each ticking a few of the 14 roles — is straightforward. It falls apart at scale. Multi-site clinical trial consortia routinely publish primary results papers with 50, 200, or even several hundred named contributors across dozens of hospitals, laboratories, and coordinating centres. Applying individual-level CRediT attribution to every one of them is rarely feasible, and the taxonomy itself offers no scaling guidance. This article examines how consortia actually resolve that gap, where the “writing committee” shortcut helps and where it hides real accountability problems, and what research administrators should check before signing off on a consortium submission.

    CASRAI originated the CRediT contributor role taxonomy in 2014. The standard is now stewarded by NISO as ANSI/NISO Z39.104-2022, an important distinction for any institution citing CRediT in policy documents.

    Contents

    What is the CRediT taxonomy and how is it meant to work?

    The CRediT (Contributor Roles Taxonomy) is a standardised list of 14 role categories — including Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Supervision, and the two Writing roles — used to describe what each named contributor to a research output actually did. Under ANSI/NISO Z39.104-2022, any of the 14 roles can be assigned to more than one contributor, and any contributor can hold more than one role. The taxonomy was designed around conventional author lists of perhaps two to twelve people, where a corresponding author can realistically survey everyone and compile an accurate statement.

    CRediT deliberately does not define who qualifies as an author — that remains the domain of criteria such as those published by the International Committee of Medical Journal Editors (ICMJE). CRediT only describes contribution once authorship, or collaborator status, has already been decided elsewhere.

    Why does individual-level CRediT attribution break down above 100 authors?

    Multi-site clinical trial consortia — platform trials, adaptive-design mega-trials, and large international collaborative groups — routinely list hundreds of contributors: principal investigators at each site, research nurses, statisticians, data monitors, and a central coordinating team. Surveying every one of them individually against 14 role definitions, reconciling disagreements, and keeping the record current through a multi-year trial is an administrative task few coordinating centres can sustain.

    Three practical failure points recur:

    • Collection burden. A corresponding author cannot manually chase 300 collaborators for role self-declarations before every manuscript revision.
    • Role granularity mismatch. Site-level staff often perform a genuinely narrow contribution (patient recruitment, sample handling) that maps to only one or two roles, making individual disclosure administratively disproportionate to its informational value.
    • Authorship-vs-collaborator ambiguity. Not every named contributor meets full authorship criteria, and CRediT provides no mechanism of its own for distinguishing the two — that decision is made upstream, under ICMJE or journal-specific rules.

    The ICMJE’s Recommendations on the role of authors and contributors state plainly: “When a large multi-author group has conducted the work, the group ideally should decide who will be an author before the work is started and confirm who is an author before submitting the manuscript for publication.” In practice, that decision — not the CRediT assignment — is what most consortia spend their governance effort on.

    How do multi-site consortia actually assign CRediT roles?

    Three models are in active use across large trial consortia, and each trades transparency against administrative load differently. The dominant compromise is a named writing committee that receives individual CRediT attribution, combined with a collective collaborative group byline (for example, “The [Trial Name] Collaborative Group”) that carries the remaining contributors without a role-by-role breakdown for each person.

    Model How it works Transparency Administrative load
    Full individual CRediT Every named author, however many, completes a role disclosure form Highest Unsustainable above roughly 30-50 authors
    Writing committee + collective group A small writing committee gets full CRediT roles; remaining contributors are credited as a named collective group, often with individual names and site affiliations in a supplementary appendix Moderate — accountable core, opaque periphery Manageable; used by most platform and mega-trials
    Hybrid tiered disclosure Writing committee gets full CRediT roles; site principal investigators get a single broad role (e.g. Investigation); frontline staff are acknowledged, not authored Higher than pure collective model Moderate, requires a pre-agreed authorship policy

    The ICMJE recommendations also clarify how this interacts with indexing: “the byline of the article identifies who is directly responsible for the manuscript,” and MEDLINE indexes as authors whichever names appear there, while non-author collaborators can still be individually listed and searchable if the journal provides an accompanying note. This means a consortium can preserve individual, searchable credit for site staff even when it does not extend full CRediT role disclosure to each of them — an option under-used by many trial groups.

    A pre-agreed authorship and contribution policy, set before a multi-site trial begins recruitment rather than at the manuscript stage, is the single factor that most reliably prevents disputes later. Waiting until submission to decide who was an “author” versus a “collaborator” — and who gets which CRediT role — is the most common cause of delay and disagreement in large consortium publications.

    Answer-first questions on CRediT and large author groups

    What are examples of author contributions?

    Typical author contributions include conceiving the study design, securing funding, recruiting patients, collecting or curating data, performing statistical analysis, writing the first draft, and critically reviewing the final manuscript. Under CRediT, each of these maps to one of 14 defined roles rather than a vague general description.

    What should substantial contributions include to be credited as an author?

    Per ICMJE criteria, a substantial contribution requires involvement in the work’s conception or design, or the acquisition, analysis, or interpretation of data, combined with drafting or critically revising the manuscript and final approval of the published version. Meeting only one element, such as data collection alone, typically warrants acknowledgement rather than authorship.

    How to write an author contribution in a case report?

    A case report contribution statement should name each author against the specific tasks they performed — for example, clinical assessment, literature review, drafting, and supervision — using plain, specific language rather than the fuller 14-role CRediT set, which is more suited to larger, multi-method studies with a genuinely divided workload.

    What this means for research administrators, funders, and publishers

    Research offices supporting multi-site consortium trials should treat CRediT and authorship decisions as a governance item from the protocol stage, not a manuscript-stage formality. A written policy — agreed by the steering committee before recruitment starts — should specify who sits on the writing committee, what threshold of involvement earns collective-group inclusion versus acknowledgement-only, and how the supplementary collaborator list will be maintained and version-controlled across a multi-year trial.

    Funders and institutions increasingly use CRediT statements as an input to research assessment, so an opaque “collective group” byline with no supplementary breakdown under-serves early-career site staff who did substantive work but receive no individually attributable, citable role. Publishers that support both a named writing committee and a searchable, named collaborator appendix — rather than a collective name alone — give institutions and funders a materially better evidence trail for exactly this reason.

    The underlying tension is not going away: CRediT was built for conventional author teams, and large trial consortia will keep testing its edges. Until a scaling mechanism is formally added to the taxonomy, the writing-committee-plus-named-collaborator-appendix model remains the most defensible practical compromise between individual accountability and administrative reality.

  • CRediT Taxonomy at Cell Press vs STAR Methods

    Cell Press embeds the CRediT taxonomy inside a highly formalised manuscript template — Summary, STAR★Methods, and a back-matter Author Contributions section — rather than treating it as a free-floating declaration bolted onto the end of a paper. The taxonomy itself sits in Author Contributions, not inside STAR★Methods, but both are governed by the same family-wide Cell Press formatting policy. That distinction matters for anyone comparing how publishers operationalise contributor-role reporting.

    The CRediT taxonomy at Cell Press journals — Cell, Cell Reports, Molecular Cell, Cell Metabolism, and the rest of the family — follows the same 14-role vocabulary used everywhere else, but the surrounding article architecture is unusually structured. CRediT is a controlled vocabulary of 14 contributor roles used to describe who did what on a research output. Understanding where Cell Press places it, and why, is useful for research administrators, publishers, and developers building submission tooling.

    What is the CRediT taxonomy at Cell Press?

    CASRAI originated the CRediT contributor role taxonomy in 2014. The standard is now stewarded by NISO as ANSI/NISO Z39.104-2022. Cell Press adopted it early: Deborah Sweet, Cell Press’s Vice President of Editorial, announced in a June 2015 Cell Mentor post that the Author Contributions section — traditional or CRediT-formatted — was being introduced as an option across Cell Press journals.

    At that point, per Sweet’s post, the section was optional unless a paper carried co-first authorship, in which case a contributions statement became necessary to clarify precedence. The taxonomy provides 14 discrete roles:

    • Conceptualization
    • Data curation
    • Formal analysis
    • Funding acquisition
    • Investigation
    • Methodology
    • Project administration
    • Resources
    • Software
    • Supervision
    • Validation
    • Visualization
    • Writing – original draft
    • Writing – review & editing

    Cell Press has never claimed ownership of the taxonomy; its published guidance credits the originating collaboration and links out to the standard, consistent with an “originator, not owner” framing that has held since 2015.

    Where does CRediT sit relative to the Summary and STAR★Methods?

    This is the section most write-ups get wrong. Cell Press’s own manuscript-preparation guidance caps the front-matter Summary at 150 words, written as a single unstructured paragraph with no citations — it is not a labelled, IMRaD-style structured abstract. The structure that gives Cell Press its reputation lives further down the paper, in STAR★Methods (Structured, Transparent, Accessible Reporting), which replaces a conventional free-text Methods section with standardised subsections: a Key Resources Table, Resource Availability, Experimental Model and Subject Details, Method Details, and Quantification and Statistical Analysis.

    CRediT itself does not sit inside STAR★Methods. It occupies its own Author Contributions block in the back matter, ordered — per the current Cell Press article template — after Acknowledgments and before Declaration of Interests and the reference list. The practical pattern is this: STAR★Methods standardises what was done and how; the CRediT-based Author Contributions statement, sitting immediately alongside it in the same standardised back matter, standardises who did it. Both are governed by one uniform, family-wide Cell Press formatting policy that applies identically whether a paper is submitted to Cell, Molecular Cell, or Cell Reports.

    That is the genuinely distinct editorial pattern: not CRediT literally nested inside STAR★Methods, but CRediT folded into the same rigid, standardised template architecture that STAR★Methods represents — a single formatting regime covering resources, methods, and contributorship together, rather than an ad hoc statement appended wherever a given journal happens to put it.

    How does this differ from the free-standing statement used elsewhere?

    Many publishers treat the Author Contributions/CRediT statement as a genuinely free-standing element: a short paragraph or table inserted near the end of the manuscript with no other structural scaffolding around it. Cell Press’s family-wide template treats it as one governed component among several.

    Feature Cell Press pattern Typical free-standing pattern
    Summary/abstract 150-word unstructured paragraph, no citations Varies by journal; often unstructured, no fixed cap
    Methods reporting Mandatory STAR★Methods with Key Resources Table Free-text Methods, no standardised subsections
    Author Contributions placement Fixed back-matter slot after Acknowledgments, before Declaration of Interests Placement varies; sometimes front matter, sometimes end matter
    CRediT status (historically) Optional unless co-first authorship (per 2015 policy) Mandatory at many journals since 2016, e.g. Journal of Cell Science, per Company of Biologists policy
    Governance One family-wide policy across all Cell Press titles Set independently per journal or per publisher imprint

    The comparison matters for anyone auditing submission systems across publishers: a developer building CRediT-aware manuscript tooling cannot assume a single fixed position for the statement, nor assume it is mandatory everywhere. Journal of Cell Science, for instance, requires CRediT-tagged contributions during online submission and states plainly that the taxonomy does not itself determine who qualifies as an author — authorship is a separate editorial decision at every publisher, Cell Press included.

    Answer-first questions on the CRediT taxonomy

    What is the CRediT taxonomy?

    The CRediT taxonomy is a controlled vocabulary of 14 contributor roles used to describe individual contributions to a research output, from conceptualization to writing – review & editing. It replaces a single vague “authorship” credit with a granular, role-by-role statement, and it is now formalised as ANSI/NISO Z39.104-2022.

    What are the 14 roles of the CRediT taxonomy?

    The 14 roles are Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, and Writing – review & editing. Any author may hold one or several roles on a single paper.

    What does investigation mean in CRediT taxonomy?

    Investigation, in CRediT terms, means conducting the research process itself — specifically performing experiments or carrying out data and evidence collection. It is distinct from Methodology (designing the approach) and from Formal analysis (applying statistical or computational techniques to the resulting data).

    Implications for administrators, publishers, and developers

    For research administrators, the Cell Press pattern is a reminder that CRediT compliance checks cannot be reduced to “is the statement present.” Where a co-first-authorship claim appears without any Author Contributions statement, that is a Cell Press-specific red flag worth raising with authors before submission, given the historical optional-unless-co-first-authors policy.

    For publishers and journal-system developers, the lesson is architectural: pairing a standardised contributorship statement with a standardised methods-reporting format, under one uniform policy, appears to reduce the drift that otherwise causes CRediT statements to vary wildly in placement and completeness across a publisher’s own journal family. As more publishers formalise their own STAR★Methods-style templates, expect more of them to fold CRediT into the same governed structure rather than leaving it as an isolated, easily skipped field.

    The underlying taxonomy remains unchanged wherever it appears. What Cell Press demonstrates is that where and how rigidly a publisher enforces CRediT — not the 14 roles themselves — is where meaningful editorial variation still exists across the scholarly-publishing landscape.

    Related reading: the CRediT taxonomy overview, the full list of CRediT contributor roles, and CASRAI’s authorship criteria resources.